IP Library Granted Patent US 7,829,105
Granted Patent B2
US 7,829,105 · App. 11/070,413 · Granted Nov 9, 2010

Compositions for repairing bone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,829,105
App. No.
11/070,413
Granted
Nov 9, 2010
Kind
B2
Abstract

This invention relates to an improved method of preparing an implantable gel or paste for placement between injured bones or placement in bony voids to induce regeneration, and the compositions produced thereby. Specifically, mineral, ceramic, or processed bone particles are coated with a high molecular weight polymer capable of forming a viscous gel when reconstituted with water, saline, autologous blood, sera, or other medically acceptable solution. This high molecular weight polymer coating material may be a natural or synthetic polymeric material, producing a wettable gel upon exposure to water, saline, or another solution. In storage, the composition will be granular and dry but easily wetted. In use, the material is reconstituted to a viscous malleable paste by the simple addition of water or other medically acceptable solution without the need for aggressive mixing. The paste may be delivered by syringe or manually deposited yet will be resistant to lavage or to displacement by gravity induced flow.

Claims (21)

1. A dry, granular composition for repairing bone, comprising bioactive particles that are capable of inducing bone growth, wherein:

said bioactive particles consist of bioactive glass particles and are individually microencapsulated with a coating comprising at least one biodegradable polymer;

the mass ratio of the bioactive particles to the coating ranges from about 1:2 to about 10:1; and

the dry, granular composition when wetted forms a syringeable paste capable of repairing bone, wherein the syringeable paste is prepared by contacting the individually microencapsulated bioactive particles with a solution.

2. The dry, granular composition of claim 1 , wherein the dry, granular composition, when wetted, forms a syringeable paste at a temperature below the gel transition temperature of the biodegradable polymer.

3. A dry, granular composition for repairing bone, comprising bioactive particles, wherein:

the bioactive particles comprise bioactive glass particles, and are individually microencapsulated with a coating comprising a biodegradable polymer,

the mass ratio of the bioactive particles to the coating ranges from about 1:2 to about 10:1,

the dry granular composition, when wetted, forms a syringeable paste capable of repairing bone; and

the bioactive particles do not include particles derived from bone.

4. The dry, granular composition of claim 3 , wherein the biodegradeable polymer is gelatin.

5. The dry, granular composition of claim 3 , wherein the bioactive particles range in size from about 750 microns to about 1.5 millimeters.

6. A dry, granular composition for repairing bone, comprising bioactive particles that are capable of inducing bone growth, wherein:

said bioactive particles consist of bioactive glass particles and are individually microencapsulated with a coating comprising at least one biodegradable polymer,

the mass ratio of the bioactive particles to the coating ranges from about 1:2 to about 10:1; and

the dry, granular composition, when wetted, forms a syringeable paste capable of repairing bone, wherein said at least one biodegradeable polymer comprises gelatin.

7. The dry, granular composition of claim 6 , wherein the dry, granular composition, when wetted, forms a syringeable paste at a temperature below the gel transition temperature of gelatin.

8. The dry, granular composition of claim 6 , further comprising a drug.

9. The dry, granular composition of claim 6 , wherein the dry, granular composition is osteoinductive.

10. The dry, granular composition of claim 6 , wherein the gelatin is porcine gelatin.

11. The dry, granular composition of claim 6 , wherein the individually microencapsulated particles range in size from about 750 microns to about 1.5 millimeters.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded May 19, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC AS AGENT
To: NANOTHERAPEUTICS, INC.
Reel/Frame 038651/0947 →
SECURITY INTEREST Recorded Mar 20, 2015
From: NANOTHERAPEUTICS, INC.
To: WHITE OAK GLOBAL ADVISORS, LLC
Reel/Frame 035236/0932 →